Drugs / CHS 828
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00003979 | Apr 1999 → ? | cancer of unknown primary site | European Organisation for Research and Treatment of Cancer - EORTC | Withdrawn | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CHS 828 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00003979 ↗ |
| Known as | GMX 1778 | ChEMBL registry synonym — accepted as the source's own label CHEMBL17289 ↗ |
| Modality | Small molecule | — CHEMBL17289 ↗ |
| Route | Oral | “CHS 828 was given orally once every 3 weeks.” PMID 15763645 ↗ Mar 2005 |